Next 10 |
home / stock / evo / evo articles
U.S. stocks traded slightly lower toward the end of trading, with the S&P 500 edging lower on Wednesday. The Dow traded down 0.18% to 38,434.99...
U.S. stocks traded mixed midway through trading, with the Dow Jones falling over 100 points on Wednesday. The Dow traded down 0.33% to 38,376.53 wh...
U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 0.5% on Wednesday. Following the market opening Wednesday, the Dow ...
Shares of Tesla, Inc. (NASDAQ:TSLA) rose sharply in today's pre-market trading following first-quarter results. Tesla posted weaker-than-expec...
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining over 70 points on Wednesday. Shares of Enphase Energy, Inc. (NASDAQ:ENP...
STOCKHOLM, Feb. 21, 2024 /PRNewswire/ -- Evolution today announced a new strategic agreement with Caesars Digital that will strengthen its existing...
Evotec SE (NASDAQ: EVO) joined forces with the Crohn's & Colitis Foundation to advance drug discovery and identify novel the...
Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial res...
Evotec SE (NASDAQ: EVO) shares are trading lower on Thursday in the premarket session. Yesterday, the company said CEO Werner Lanthaler s...
News, Short Squeeze, Breakout and More Instantly...
Evotec SE Company Name:
EVO Stock Symbol:
NYSE Market:
HAMBURG, GERMANY / ACCESSWIRE / May 15, 2024 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its financial results for the first quarter of 2024 on Wednesday, 22 May 2024. The Company is going to hold a conference call to discuss the resul...
CENTOGENE to receive license fee providing Evotec with R&D license to complete next phase of pre-clinical research Companies amend existing drug discovery partnership for Evotec to lead continued development. Upon Evotec exercising its option, CENTOGENE to receive an option exercise f...
2024-05-10 19:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...